Trending News Today: Trump Administration Seeks to Require Disclosure of Health Care Costs

On Monday, President Donald Trump signed an executive order that requires the disclosure of health care costs to patients in an effort to improve transparency, The Associated Press reported. According to the article, the order would compel hospitals to publicize information on their negotiated rates for many common tests and procedures, which could enable patients to shop around for the best prices. However, the executive order calls for a rule-making process by federal agencies, which typically takes months or even years, the article reported.
 
Officials with the FDA have removed a partial clinical hold on AbbVie’s CANOVA (M13-494) study of venetoclax (Venclexta or Venclyxto) for patients with multiple myeloma, The American Journal of Managed Care reported. According to the article, the FDA had previously ordered a partial clinical hold on all venetoclax-related trials when the results from the BELLINI study showed a disproportionate number of deaths in patients treated with venetoclax. Regulators lifted the partial clinical hold based upon an agreement that the study protocol be revised, the article reported.
 
Novartis won a US federal court order preventing generic makers from selling versions of its multiple sclerosis drug fingolimod (Gilenya), Reuters reported. According to the article, Novartis had asked for a preliminary injunction to halt generic drug makers, including Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, Torrent Pharma, and Aurobindo Pharma, from making or selling generic versions of Gilenya in the United States. Although the patent term extension expires in 2019, Novartis argued that a patent on how the drug is dosed that does not expire until 2027 should extend its exclusivity, the article reported.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$